Global Biopharma Buffer Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
LPI (LP Information)' newest research report, the “Biopharma Buffer Industry Forecast” looks at past sales and reviews total world Biopharma Buffer sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharma Buffer sales for 2023 through 2029. With Biopharma Buffer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharma Buffer industry.
This Insight Report provides a comprehensive analysis of the global Biopharma Buffer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharma Buffer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biopharma Buffer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharma Buffer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharma Buffer.
The global Biopharma Buffer market size is projected to grow from US$ 823.1 million in 2022 to US$ 1049.1 million in 2029; it is expected to grow at a CAGR of 1049.1 from 2023 to 2029.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharma Buffer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biopharma Buffer market?
What factors are driving Biopharma Buffer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biopharma Buffer market opportunities vary by end market size?
How does Biopharma Buffer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
LPI (LP Information)' newest research report, the “Biopharma Buffer Industry Forecast” looks at past sales and reviews total world Biopharma Buffer sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharma Buffer sales for 2023 through 2029. With Biopharma Buffer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharma Buffer industry.
This Insight Report provides a comprehensive analysis of the global Biopharma Buffer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharma Buffer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biopharma Buffer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharma Buffer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharma Buffer.
The global Biopharma Buffer market size is projected to grow from US$ 823.1 million in 2022 to US$ 1049.1 million in 2029; it is expected to grow at a CAGR of 1049.1 from 2023 to 2029.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharma Buffer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Phosphates Type
- Acetates Type
- TRIS Type
- Others
- Research Institution
- Pharmaceutical Industry
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Avantor
- Alfa Aesar (Thermo Fisher)
- Merck
- Lonza
- Bio-Rad
- BD
- GE Healthcare
- Promega Corporation
- Hamilton Company
- XZL BIO-TECHNOLOGY
- SRL
What is the 10-year outlook for the global Biopharma Buffer market?
What factors are driving Biopharma Buffer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biopharma Buffer market opportunities vary by end market size?
How does Biopharma Buffer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharma Buffer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biopharma Buffer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biopharma Buffer by Country/Region, 2018, 2022 & 2029
2.2 Biopharma Buffer Segment by Type
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
2.3 Biopharma Buffer Sales by Type
2.3.1 Global Biopharma Buffer Sales Market Share by Type (2018-2023)
2.3.2 Global Biopharma Buffer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biopharma Buffer Sale Price by Type (2018-2023)
2.4 Biopharma Buffer Segment by Application
2.4.1 Research Institution
2.4.2 Pharmaceutical Industry
2.4.3 Others
2.5 Biopharma Buffer Sales by Application
2.5.1 Global Biopharma Buffer Sale Market Share by Application (2018-2023)
2.5.2 Global Biopharma Buffer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biopharma Buffer Sale Price by Application (2018-2023)
3 GLOBAL BIOPHARMA BUFFER BY COMPANY
3.1 Global Biopharma Buffer Breakdown Data by Company
3.1.1 Global Biopharma Buffer Annual Sales by Company (2018-2023)
3.1.2 Global Biopharma Buffer Sales Market Share by Company (2018-2023)
3.2 Global Biopharma Buffer Annual Revenue by Company (2018-2023)
3.2.1 Global Biopharma Buffer Revenue by Company (2018-2023)
3.2.2 Global Biopharma Buffer Revenue Market Share by Company (2018-2023)
3.3 Global Biopharma Buffer Sale Price by Company
3.4 Key Manufacturers Biopharma Buffer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharma Buffer Product Location Distribution
3.4.2 Players Biopharma Buffer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOPHARMA BUFFER BY GEOGRAPHIC REGION
4.1 World Historic Biopharma Buffer Market Size by Geographic Region (2018-2023)
4.1.1 Global Biopharma Buffer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biopharma Buffer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biopharma Buffer Market Size by Country/Region (2018-2023)
4.2.1 Global Biopharma Buffer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biopharma Buffer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biopharma Buffer Sales Growth
4.4 APAC Biopharma Buffer Sales Growth
4.5 Europe Biopharma Buffer Sales Growth
4.6 Middle East & Africa Biopharma Buffer Sales Growth
5 AMERICAS
5.1 Americas Biopharma Buffer Sales by Country
5.1.1 Americas Biopharma Buffer Sales by Country (2018-2023)
5.1.2 Americas Biopharma Buffer Revenue by Country (2018-2023)
5.2 Americas Biopharma Buffer Sales by Type
5.3 Americas Biopharma Buffer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharma Buffer Sales by Region
6.1.1 APAC Biopharma Buffer Sales by Region (2018-2023)
6.1.2 APAC Biopharma Buffer Revenue by Region (2018-2023)
6.2 APAC Biopharma Buffer Sales by Type
6.3 APAC Biopharma Buffer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biopharma Buffer by Country
7.1.1 Europe Biopharma Buffer Sales by Country (2018-2023)
7.1.2 Europe Biopharma Buffer Revenue by Country (2018-2023)
7.2 Europe Biopharma Buffer Sales by Type
7.3 Europe Biopharma Buffer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharma Buffer by Country
8.1.1 Middle East & Africa Biopharma Buffer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biopharma Buffer Revenue by Country (2018-2023)
8.2 Middle East & Africa Biopharma Buffer Sales by Type
8.3 Middle East & Africa Biopharma Buffer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharma Buffer
10.3 Manufacturing Process Analysis of Biopharma Buffer
10.4 Industry Chain Structure of Biopharma Buffer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharma Buffer Distributors
11.3 Biopharma Buffer Customer
12 WORLD FORECAST REVIEW FOR BIOPHARMA BUFFER BY GEOGRAPHIC REGION
12.1 Global Biopharma Buffer Market Size Forecast by Region
12.1.1 Global Biopharma Buffer Forecast by Region (2024-2029)
12.1.2 Global Biopharma Buffer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biopharma Buffer Forecast by Type
12.7 Global Biopharma Buffer Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Avantor
13.1.1 Avantor Company Information
13.1.2 Avantor Biopharma Buffer Product Portfolios and Specifications
13.1.3 Avantor Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Avantor Main Business Overview
13.1.5 Avantor Latest Developments
13.2 Alfa Aesar (Thermo Fisher)
13.2.1 Alfa Aesar (Thermo Fisher) Company Information
13.2.2 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Portfolios and Specifications
13.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alfa Aesar (Thermo Fisher) Main Business Overview
13.2.5 Alfa Aesar (Thermo Fisher) Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Biopharma Buffer Product Portfolios and Specifications
13.3.3 Merck Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza Biopharma Buffer Product Portfolios and Specifications
13.4.3 Lonza Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Biopharma Buffer Product Portfolios and Specifications
13.5.3 Bio-Rad Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Biopharma Buffer Product Portfolios and Specifications
13.6.3 BD Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 GE Healthcare
13.7.1 GE Healthcare Company Information
13.7.2 GE Healthcare Biopharma Buffer Product Portfolios and Specifications
13.7.3 GE Healthcare Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GE Healthcare Main Business Overview
13.7.5 GE Healthcare Latest Developments
13.8 Promega Corporation
13.8.1 Promega Corporation Company Information
13.8.2 Promega Corporation Biopharma Buffer Product Portfolios and Specifications
13.8.3 Promega Corporation Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Promega Corporation Main Business Overview
13.8.5 Promega Corporation Latest Developments
13.9 Hamilton Company
13.9.1 Hamilton Company Company Information
13.9.2 Hamilton Company Biopharma Buffer Product Portfolios and Specifications
13.9.3 Hamilton Company Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hamilton Company Main Business Overview
13.9.5 Hamilton Company Latest Developments
13.10 XZL BIO-TECHNOLOGY
13.10.1 XZL BIO-TECHNOLOGY Company Information
13.10.2 XZL BIO-TECHNOLOGY Biopharma Buffer Product Portfolios and Specifications
13.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 XZL BIO-TECHNOLOGY Main Business Overview
13.10.5 XZL BIO-TECHNOLOGY Latest Developments
13.11 SRL
13.11.1 SRL Company Information
13.11.2 SRL Biopharma Buffer Product Portfolios and Specifications
13.11.3 SRL Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SRL Main Business Overview
13.11.5 SRL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharma Buffer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biopharma Buffer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biopharma Buffer by Country/Region, 2018, 2022 & 2029
2.2 Biopharma Buffer Segment by Type
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
2.3 Biopharma Buffer Sales by Type
2.3.1 Global Biopharma Buffer Sales Market Share by Type (2018-2023)
2.3.2 Global Biopharma Buffer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biopharma Buffer Sale Price by Type (2018-2023)
2.4 Biopharma Buffer Segment by Application
2.4.1 Research Institution
2.4.2 Pharmaceutical Industry
2.4.3 Others
2.5 Biopharma Buffer Sales by Application
2.5.1 Global Biopharma Buffer Sale Market Share by Application (2018-2023)
2.5.2 Global Biopharma Buffer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biopharma Buffer Sale Price by Application (2018-2023)
3 GLOBAL BIOPHARMA BUFFER BY COMPANY
3.1 Global Biopharma Buffer Breakdown Data by Company
3.1.1 Global Biopharma Buffer Annual Sales by Company (2018-2023)
3.1.2 Global Biopharma Buffer Sales Market Share by Company (2018-2023)
3.2 Global Biopharma Buffer Annual Revenue by Company (2018-2023)
3.2.1 Global Biopharma Buffer Revenue by Company (2018-2023)
3.2.2 Global Biopharma Buffer Revenue Market Share by Company (2018-2023)
3.3 Global Biopharma Buffer Sale Price by Company
3.4 Key Manufacturers Biopharma Buffer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharma Buffer Product Location Distribution
3.4.2 Players Biopharma Buffer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOPHARMA BUFFER BY GEOGRAPHIC REGION
4.1 World Historic Biopharma Buffer Market Size by Geographic Region (2018-2023)
4.1.1 Global Biopharma Buffer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biopharma Buffer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biopharma Buffer Market Size by Country/Region (2018-2023)
4.2.1 Global Biopharma Buffer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biopharma Buffer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biopharma Buffer Sales Growth
4.4 APAC Biopharma Buffer Sales Growth
4.5 Europe Biopharma Buffer Sales Growth
4.6 Middle East & Africa Biopharma Buffer Sales Growth
5 AMERICAS
5.1 Americas Biopharma Buffer Sales by Country
5.1.1 Americas Biopharma Buffer Sales by Country (2018-2023)
5.1.2 Americas Biopharma Buffer Revenue by Country (2018-2023)
5.2 Americas Biopharma Buffer Sales by Type
5.3 Americas Biopharma Buffer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharma Buffer Sales by Region
6.1.1 APAC Biopharma Buffer Sales by Region (2018-2023)
6.1.2 APAC Biopharma Buffer Revenue by Region (2018-2023)
6.2 APAC Biopharma Buffer Sales by Type
6.3 APAC Biopharma Buffer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biopharma Buffer by Country
7.1.1 Europe Biopharma Buffer Sales by Country (2018-2023)
7.1.2 Europe Biopharma Buffer Revenue by Country (2018-2023)
7.2 Europe Biopharma Buffer Sales by Type
7.3 Europe Biopharma Buffer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharma Buffer by Country
8.1.1 Middle East & Africa Biopharma Buffer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biopharma Buffer Revenue by Country (2018-2023)
8.2 Middle East & Africa Biopharma Buffer Sales by Type
8.3 Middle East & Africa Biopharma Buffer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharma Buffer
10.3 Manufacturing Process Analysis of Biopharma Buffer
10.4 Industry Chain Structure of Biopharma Buffer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharma Buffer Distributors
11.3 Biopharma Buffer Customer
12 WORLD FORECAST REVIEW FOR BIOPHARMA BUFFER BY GEOGRAPHIC REGION
12.1 Global Biopharma Buffer Market Size Forecast by Region
12.1.1 Global Biopharma Buffer Forecast by Region (2024-2029)
12.1.2 Global Biopharma Buffer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biopharma Buffer Forecast by Type
12.7 Global Biopharma Buffer Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Avantor
13.1.1 Avantor Company Information
13.1.2 Avantor Biopharma Buffer Product Portfolios and Specifications
13.1.3 Avantor Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Avantor Main Business Overview
13.1.5 Avantor Latest Developments
13.2 Alfa Aesar (Thermo Fisher)
13.2.1 Alfa Aesar (Thermo Fisher) Company Information
13.2.2 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Portfolios and Specifications
13.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alfa Aesar (Thermo Fisher) Main Business Overview
13.2.5 Alfa Aesar (Thermo Fisher) Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Biopharma Buffer Product Portfolios and Specifications
13.3.3 Merck Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza Biopharma Buffer Product Portfolios and Specifications
13.4.3 Lonza Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Biopharma Buffer Product Portfolios and Specifications
13.5.3 Bio-Rad Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Biopharma Buffer Product Portfolios and Specifications
13.6.3 BD Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 GE Healthcare
13.7.1 GE Healthcare Company Information
13.7.2 GE Healthcare Biopharma Buffer Product Portfolios and Specifications
13.7.3 GE Healthcare Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GE Healthcare Main Business Overview
13.7.5 GE Healthcare Latest Developments
13.8 Promega Corporation
13.8.1 Promega Corporation Company Information
13.8.2 Promega Corporation Biopharma Buffer Product Portfolios and Specifications
13.8.3 Promega Corporation Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Promega Corporation Main Business Overview
13.8.5 Promega Corporation Latest Developments
13.9 Hamilton Company
13.9.1 Hamilton Company Company Information
13.9.2 Hamilton Company Biopharma Buffer Product Portfolios and Specifications
13.9.3 Hamilton Company Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hamilton Company Main Business Overview
13.9.5 Hamilton Company Latest Developments
13.10 XZL BIO-TECHNOLOGY
13.10.1 XZL BIO-TECHNOLOGY Company Information
13.10.2 XZL BIO-TECHNOLOGY Biopharma Buffer Product Portfolios and Specifications
13.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 XZL BIO-TECHNOLOGY Main Business Overview
13.10.5 XZL BIO-TECHNOLOGY Latest Developments
13.11 SRL
13.11.1 SRL Company Information
13.11.2 SRL Biopharma Buffer Product Portfolios and Specifications
13.11.3 SRL Biopharma Buffer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SRL Main Business Overview
13.11.5 SRL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharma Buffer Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biopharma Buffer Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Phosphates Type
Table 4. Major Players of Acetates Type
Table 5. Major Players of TRIS Type
Table 6. Major Players of Others
Table 7. Global Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 8. Global Biopharma Buffer Sales Market Share by Type (2018-2023)
Table 9. Global Biopharma Buffer Revenue by Type (2018-2023) & ($ million)
Table 10. Global Biopharma Buffer Revenue Market Share by Type (2018-2023)
Table 11. Global Biopharma Buffer Sale Price by Type (2018-2023) & (US$/L)
Table 12. Global Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 13. Global Biopharma Buffer Sales Market Share by Application (2018-2023)
Table 14. Global Biopharma Buffer Revenue by Application (2018-2023)
Table 15. Global Biopharma Buffer Revenue Market Share by Application (2018-2023)
Table 16. Global Biopharma Buffer Sale Price by Application (2018-2023) & (US$/L)
Table 17. Global Biopharma Buffer Sales by Company (2018-2023) & (KL)
Table 18. Global Biopharma Buffer Sales Market Share by Company (2018-2023)
Table 19. Global Biopharma Buffer Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Biopharma Buffer Revenue Market Share by Company (2018-2023)
Table 21. Global Biopharma Buffer Sale Price by Company (2018-2023) & (US$/L)
Table 22. Key Manufacturers Biopharma Buffer Producing Area Distribution and Sales Area
Table 23. Players Biopharma Buffer Products Offered
Table 24. Biopharma Buffer Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biopharma Buffer Sales by Geographic Region (2018-2023) & (KL)
Table 28. Global Biopharma Buffer Sales Market Share Geographic Region (2018-2023)
Table 29. Global Biopharma Buffer Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Biopharma Buffer Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Biopharma Buffer Sales by Country/Region (2018-2023) & (KL)
Table 32. Global Biopharma Buffer Sales Market Share by Country/Region (2018-2023)
Table 33. Global Biopharma Buffer Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Biopharma Buffer Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 36. Americas Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 37. Americas Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 39. Americas Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 40. Americas Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 41. APAC Biopharma Buffer Sales by Region (2018-2023) & (KL)
Table 42. APAC Biopharma Buffer Sales Market Share by Region (2018-2023)
Table 43. APAC Biopharma Buffer Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Biopharma Buffer Revenue Market Share by Region (2018-2023)
Table 45. APAC Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 46. APAC Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 47. Europe Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 48. Europe Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 49. Europe Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 51. Europe Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 52. Europe Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 53. Middle East & Africa Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 54. Middle East & Africa Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 58. Middle East & Africa Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 59. Key Market Drivers & Growth Opportunities of Biopharma Buffer
Table 60. Key Market Challenges & Risks of Biopharma Buffer
Table 61. Key Industry Trends of Biopharma Buffer
Table 62. Biopharma Buffer Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Biopharma Buffer Distributors List
Table 65. Biopharma Buffer Customer List
Table 66. Global Biopharma Buffer Sales Forecast by Region (2024-2029) & (KL)
Table 67. Global Biopharma Buffer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 69. Americas Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Biopharma Buffer Sales Forecast by Region (2024-2029) & (KL)
Table 71. APAC Biopharma Buffer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 73. Europe Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 75. Middle East & Africa Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Biopharma Buffer Sales Forecast by Type (2024-2029) & (KL)
Table 77. Global Biopharma Buffer Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Biopharma Buffer Sales Forecast by Application (2024-2029) & (KL)
Table 79. Global Biopharma Buffer Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Avantor Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 81. Avantor Biopharma Buffer Product Portfolios and Specifications
Table 82. Avantor Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Avantor Main Business
Table 84. Avantor Latest Developments
Table 85. Alfa Aesar (Thermo Fisher) Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 86. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Portfolios and Specifications
Table 87. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Alfa Aesar (Thermo Fisher) Main Business
Table 89. Alfa Aesar (Thermo Fisher) Latest Developments
Table 90. Merck Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Biopharma Buffer Product Portfolios and Specifications
Table 92. Merck Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Lonza Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 96. Lonza Biopharma Buffer Product Portfolios and Specifications
Table 97. Lonza Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Lonza Main Business
Table 99. Lonza Latest Developments
Table 100. Bio-Rad Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 101. Bio-Rad Biopharma Buffer Product Portfolios and Specifications
Table 102. Bio-Rad Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Bio-Rad Main Business
Table 104. Bio-Rad Latest Developments
Table 105. BD Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 106. BD Biopharma Buffer Product Portfolios and Specifications
Table 107. BD Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 108. BD Main Business
Table 109. BD Latest Developments
Table 110. GE Healthcare Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 111. GE Healthcare Biopharma Buffer Product Portfolios and Specifications
Table 112. GE Healthcare Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 113. GE Healthcare Main Business
Table 114. GE Healthcare Latest Developments
Table 115. Promega Corporation Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 116. Promega Corporation Biopharma Buffer Product Portfolios and Specifications
Table 117. Promega Corporation Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 118. Promega Corporation Main Business
Table 119. Promega Corporation Latest Developments
Table 120. Hamilton Company Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 121. Hamilton Company Biopharma Buffer Product Portfolios and Specifications
Table 122. Hamilton Company Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 123. Hamilton Company Main Business
Table 124. Hamilton Company Latest Developments
Table 125. XZL BIO-TECHNOLOGY Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 126. XZL BIO-TECHNOLOGY Biopharma Buffer Product Portfolios and Specifications
Table 127. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 128. XZL BIO-TECHNOLOGY Main Business
Table 129. XZL BIO-TECHNOLOGY Latest Developments
Table 130. SRL Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 131. SRL Biopharma Buffer Product Portfolios and Specifications
Table 132. SRL Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 133. SRL Main Business
Table 134. SRL Latest Developments
Table 1. Biopharma Buffer Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biopharma Buffer Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Phosphates Type
Table 4. Major Players of Acetates Type
Table 5. Major Players of TRIS Type
Table 6. Major Players of Others
Table 7. Global Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 8. Global Biopharma Buffer Sales Market Share by Type (2018-2023)
Table 9. Global Biopharma Buffer Revenue by Type (2018-2023) & ($ million)
Table 10. Global Biopharma Buffer Revenue Market Share by Type (2018-2023)
Table 11. Global Biopharma Buffer Sale Price by Type (2018-2023) & (US$/L)
Table 12. Global Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 13. Global Biopharma Buffer Sales Market Share by Application (2018-2023)
Table 14. Global Biopharma Buffer Revenue by Application (2018-2023)
Table 15. Global Biopharma Buffer Revenue Market Share by Application (2018-2023)
Table 16. Global Biopharma Buffer Sale Price by Application (2018-2023) & (US$/L)
Table 17. Global Biopharma Buffer Sales by Company (2018-2023) & (KL)
Table 18. Global Biopharma Buffer Sales Market Share by Company (2018-2023)
Table 19. Global Biopharma Buffer Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Biopharma Buffer Revenue Market Share by Company (2018-2023)
Table 21. Global Biopharma Buffer Sale Price by Company (2018-2023) & (US$/L)
Table 22. Key Manufacturers Biopharma Buffer Producing Area Distribution and Sales Area
Table 23. Players Biopharma Buffer Products Offered
Table 24. Biopharma Buffer Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biopharma Buffer Sales by Geographic Region (2018-2023) & (KL)
Table 28. Global Biopharma Buffer Sales Market Share Geographic Region (2018-2023)
Table 29. Global Biopharma Buffer Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Biopharma Buffer Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Biopharma Buffer Sales by Country/Region (2018-2023) & (KL)
Table 32. Global Biopharma Buffer Sales Market Share by Country/Region (2018-2023)
Table 33. Global Biopharma Buffer Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Biopharma Buffer Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 36. Americas Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 37. Americas Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 39. Americas Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 40. Americas Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 41. APAC Biopharma Buffer Sales by Region (2018-2023) & (KL)
Table 42. APAC Biopharma Buffer Sales Market Share by Region (2018-2023)
Table 43. APAC Biopharma Buffer Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Biopharma Buffer Revenue Market Share by Region (2018-2023)
Table 45. APAC Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 46. APAC Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 47. Europe Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 48. Europe Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 49. Europe Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 51. Europe Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 52. Europe Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 53. Middle East & Africa Biopharma Buffer Sales by Country (2018-2023) & (KL)
Table 54. Middle East & Africa Biopharma Buffer Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biopharma Buffer Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Biopharma Buffer Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Biopharma Buffer Sales by Type (2018-2023) & (KL)
Table 58. Middle East & Africa Biopharma Buffer Sales by Application (2018-2023) & (KL)
Table 59. Key Market Drivers & Growth Opportunities of Biopharma Buffer
Table 60. Key Market Challenges & Risks of Biopharma Buffer
Table 61. Key Industry Trends of Biopharma Buffer
Table 62. Biopharma Buffer Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Biopharma Buffer Distributors List
Table 65. Biopharma Buffer Customer List
Table 66. Global Biopharma Buffer Sales Forecast by Region (2024-2029) & (KL)
Table 67. Global Biopharma Buffer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 69. Americas Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Biopharma Buffer Sales Forecast by Region (2024-2029) & (KL)
Table 71. APAC Biopharma Buffer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 73. Europe Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Biopharma Buffer Sales Forecast by Country (2024-2029) & (KL)
Table 75. Middle East & Africa Biopharma Buffer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Biopharma Buffer Sales Forecast by Type (2024-2029) & (KL)
Table 77. Global Biopharma Buffer Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Biopharma Buffer Sales Forecast by Application (2024-2029) & (KL)
Table 79. Global Biopharma Buffer Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Avantor Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 81. Avantor Biopharma Buffer Product Portfolios and Specifications
Table 82. Avantor Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Avantor Main Business
Table 84. Avantor Latest Developments
Table 85. Alfa Aesar (Thermo Fisher) Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 86. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Portfolios and Specifications
Table 87. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Alfa Aesar (Thermo Fisher) Main Business
Table 89. Alfa Aesar (Thermo Fisher) Latest Developments
Table 90. Merck Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Biopharma Buffer Product Portfolios and Specifications
Table 92. Merck Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Lonza Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 96. Lonza Biopharma Buffer Product Portfolios and Specifications
Table 97. Lonza Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Lonza Main Business
Table 99. Lonza Latest Developments
Table 100. Bio-Rad Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 101. Bio-Rad Biopharma Buffer Product Portfolios and Specifications
Table 102. Bio-Rad Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Bio-Rad Main Business
Table 104. Bio-Rad Latest Developments
Table 105. BD Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 106. BD Biopharma Buffer Product Portfolios and Specifications
Table 107. BD Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 108. BD Main Business
Table 109. BD Latest Developments
Table 110. GE Healthcare Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 111. GE Healthcare Biopharma Buffer Product Portfolios and Specifications
Table 112. GE Healthcare Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 113. GE Healthcare Main Business
Table 114. GE Healthcare Latest Developments
Table 115. Promega Corporation Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 116. Promega Corporation Biopharma Buffer Product Portfolios and Specifications
Table 117. Promega Corporation Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 118. Promega Corporation Main Business
Table 119. Promega Corporation Latest Developments
Table 120. Hamilton Company Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 121. Hamilton Company Biopharma Buffer Product Portfolios and Specifications
Table 122. Hamilton Company Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 123. Hamilton Company Main Business
Table 124. Hamilton Company Latest Developments
Table 125. XZL BIO-TECHNOLOGY Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 126. XZL BIO-TECHNOLOGY Biopharma Buffer Product Portfolios and Specifications
Table 127. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 128. XZL BIO-TECHNOLOGY Main Business
Table 129. XZL BIO-TECHNOLOGY Latest Developments
Table 130. SRL Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 131. SRL Biopharma Buffer Product Portfolios and Specifications
Table 132. SRL Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 133. SRL Main Business
Table 134. SRL Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biopharma Buffer
Figure 2. Biopharma Buffer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharma Buffer Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Biopharma Buffer Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biopharma Buffer Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Phosphates Type
Figure 10. Product Picture of Acetates Type
Figure 11. Product Picture of TRIS Type
Figure 12. Product Picture of Others
Figure 13. Global Biopharma Buffer Sales Market Share by Type in 2022
Figure 14. Global Biopharma Buffer Revenue Market Share by Type (2018-2023)
Figure 15. Biopharma Buffer Consumed in Research Institution
Figure 16. Global Biopharma Buffer Market: Research Institution (2018-2023) & (KL)
Figure 17. Biopharma Buffer Consumed in Pharmaceutical Industry
Figure 18. Global Biopharma Buffer Market: Pharmaceutical Industry (2018-2023) & (KL)
Figure 19. Biopharma Buffer Consumed in Others
Figure 20. Global Biopharma Buffer Market: Others (2018-2023) & (KL)
Figure 21. Global Biopharma Buffer Sales Market Share by Application (2022)
Figure 22. Global Biopharma Buffer Revenue Market Share by Application in 2022
Figure 23. Biopharma Buffer Sales Market by Company in 2022 (KL)
Figure 24. Global Biopharma Buffer Sales Market Share by Company in 2022
Figure 25. Biopharma Buffer Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Biopharma Buffer Revenue Market Share by Company in 2022
Figure 27. Global Biopharma Buffer Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Biopharma Buffer Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Biopharma Buffer Sales 2018-2023 (KL)
Figure 30. Americas Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 31. APAC Biopharma Buffer Sales 2018-2023 (KL)
Figure 32. APAC Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 33. Europe Biopharma Buffer Sales 2018-2023 (KL)
Figure 34. Europe Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Biopharma Buffer Sales 2018-2023 (KL)
Figure 36. Middle East & Africa Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 37. Americas Biopharma Buffer Sales Market Share by Country in 2022
Figure 38. Americas Biopharma Buffer Revenue Market Share by Country in 2022
Figure 39. Americas Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 40. Americas Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 41. United States Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Biopharma Buffer Sales Market Share by Region in 2022
Figure 46. APAC Biopharma Buffer Revenue Market Share by Regions in 2022
Figure 47. APAC Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 48. APAC Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 49. China Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Biopharma Buffer Sales Market Share by Country in 2022
Figure 57. Europe Biopharma Buffer Revenue Market Share by Country in 2022
Figure 58. Europe Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 59. Europe Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 60. Germany Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Biopharma Buffer Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Biopharma Buffer Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 69. Egypt Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Biopharma Buffer in 2022
Figure 75. Manufacturing Process Analysis of Biopharma Buffer
Figure 76. Industry Chain Structure of Biopharma Buffer
Figure 77. Channels of Distribution
Figure 78. Global Biopharma Buffer Sales Market Forecast by Region (2024-2029)
Figure 79. Global Biopharma Buffer Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Biopharma Buffer Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Biopharma Buffer Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Biopharma Buffer Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Biopharma Buffer Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biopharma Buffer
Figure 2. Biopharma Buffer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharma Buffer Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Biopharma Buffer Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biopharma Buffer Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Phosphates Type
Figure 10. Product Picture of Acetates Type
Figure 11. Product Picture of TRIS Type
Figure 12. Product Picture of Others
Figure 13. Global Biopharma Buffer Sales Market Share by Type in 2022
Figure 14. Global Biopharma Buffer Revenue Market Share by Type (2018-2023)
Figure 15. Biopharma Buffer Consumed in Research Institution
Figure 16. Global Biopharma Buffer Market: Research Institution (2018-2023) & (KL)
Figure 17. Biopharma Buffer Consumed in Pharmaceutical Industry
Figure 18. Global Biopharma Buffer Market: Pharmaceutical Industry (2018-2023) & (KL)
Figure 19. Biopharma Buffer Consumed in Others
Figure 20. Global Biopharma Buffer Market: Others (2018-2023) & (KL)
Figure 21. Global Biopharma Buffer Sales Market Share by Application (2022)
Figure 22. Global Biopharma Buffer Revenue Market Share by Application in 2022
Figure 23. Biopharma Buffer Sales Market by Company in 2022 (KL)
Figure 24. Global Biopharma Buffer Sales Market Share by Company in 2022
Figure 25. Biopharma Buffer Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Biopharma Buffer Revenue Market Share by Company in 2022
Figure 27. Global Biopharma Buffer Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Biopharma Buffer Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Biopharma Buffer Sales 2018-2023 (KL)
Figure 30. Americas Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 31. APAC Biopharma Buffer Sales 2018-2023 (KL)
Figure 32. APAC Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 33. Europe Biopharma Buffer Sales 2018-2023 (KL)
Figure 34. Europe Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Biopharma Buffer Sales 2018-2023 (KL)
Figure 36. Middle East & Africa Biopharma Buffer Revenue 2018-2023 ($ Millions)
Figure 37. Americas Biopharma Buffer Sales Market Share by Country in 2022
Figure 38. Americas Biopharma Buffer Revenue Market Share by Country in 2022
Figure 39. Americas Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 40. Americas Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 41. United States Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Biopharma Buffer Sales Market Share by Region in 2022
Figure 46. APAC Biopharma Buffer Revenue Market Share by Regions in 2022
Figure 47. APAC Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 48. APAC Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 49. China Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Biopharma Buffer Sales Market Share by Country in 2022
Figure 57. Europe Biopharma Buffer Revenue Market Share by Country in 2022
Figure 58. Europe Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 59. Europe Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 60. Germany Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Biopharma Buffer Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Biopharma Buffer Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Biopharma Buffer Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Biopharma Buffer Sales Market Share by Application (2018-2023)
Figure 69. Egypt Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Biopharma Buffer Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Biopharma Buffer in 2022
Figure 75. Manufacturing Process Analysis of Biopharma Buffer
Figure 76. Industry Chain Structure of Biopharma Buffer
Figure 77. Channels of Distribution
Figure 78. Global Biopharma Buffer Sales Market Forecast by Region (2024-2029)
Figure 79. Global Biopharma Buffer Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Biopharma Buffer Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Biopharma Buffer Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Biopharma Buffer Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Biopharma Buffer Revenue Market Share Forecast by Application (2024-2029)
